TY  - GEN
AU  - Bennouna,Jaafar
AU  - Deslandres,Marion
AU  - Senellart,Helene
AU  - de Labareyre,Cecile
AU  - Ruiz-Soto,Rodrigo
AU  - Wixon,Claire
AU  - Botbyl,Jeff
AU  - Suttle,A Benjamin
AU  - Delord,Jean-Pierre
TI  - A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer
SN  - 1573-0646
PY  - 2015///0918
KW  - Adult
KW  - Aged
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Camptothecin
KW  - Cetuximab
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Indazoles
KW  - Irinotecan
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neutropenia
KW  - chemically induced
KW  - Protein Kinase Inhibitors
KW  - Pyrimidines
KW  - Recurrence
KW  - Sulfonamides
KW  - Topoisomerase I Inhibitors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10637-014-0142-1
ER  -